Medpace Holdings, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Medpace Holdings, Inc. (MEDP) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $45.40 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-07-23
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $45.40M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $47.05M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $44.04M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $46.00M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $45.40M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $47.05M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $44.04M 10-K · filed 2026-02-10 |
| 2025-09-30 | $46.00M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $48.07M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $49.46M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $50.57M 10-K · filed 2025-02-11 |
| 2024-09-30 | $52.05M 10-Q · filed 2024-10-22 |
| 2024-06-30 | $53.88M 10-Q · filed 2024-07-23 |
| 2024-03-31 | $55.73M 10-Q · filed 2024-04-23 |
| 2023-12-31 | $57.98M 10-K · filed 2024-02-13 |
| 2023-09-30 | $58.22M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $58.72M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $60.58M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $59.21M 10-K · filed 2023-02-14 |
| 2022-09-30 | $60.67M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $61.11M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $63.29M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $63.79M 10-K · filed 2022-02-15 |
| 2021-09-30 | $65.31M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $62.30M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $63.81M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $65.44M 10-K · filed 2021-02-16 |
| 2020-09-30 | $62.36M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $65.72M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $12.36M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $12.35M 10-K · filed 2020-02-25 |
| 2019-09-30 | $12.87M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $11.16M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $11.96M 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |